AmResearch retains Hold on Petronas Chemicals


Affun Hwang Research has downgraded the counter from a

KUALA LUMPUR: AmResearch is maintaining its Hold rating rating on Petronas Chemicals Group (PChem) with an unchanged fair value of RM6.36 a share.

The research house said on Tuesday the fair value was pegged to a FY16F enterprise value/ earnings before interest, tax, depreciation and amortisation (EV/EBITDA) of 8.5 times (based on a 50% premium to PTT Global Chemicals).

To recap, PChem’s unit PRPC Polymers Sdn Bhd had awarded a US$482mil (RM2bil) contract to build a 900,000 tonnes per annum (900 ktpa) polypropylene plant to an Italian-Chinese consortium comprising Italy-based Tecnimonth S.p.A, and China’s Huanqiu Contracting & Eng. Corp.

The plant would be built within the Refinery and Petrochemicals Integrated Development (RAPID).  The contract, starting on Nov 23, was expected to be completed in April 2019.   

“This is within our expectations as we have indicated in our report on Nov 4 that PChem has reached a final investment decision for RAPID petrochemical facility in Pengerang, Johor. As this project is expected to cost US$3.9bil (RM16.8bil), we expect further announcements over the next few months to other contractors.

“Assuming a project IRR of 12%, we estimate that the entire stake in this petrochemical project could generate an earnings accretion of RM1.8bil or 67% of FY15F earnings,” it said. 

AmResearch said while the group’s long-term prospects are favourable, the outlook for product prices remains mixed in the near-term as a likely improvement in olefins and derivatives, supported by supply constraints by Middle-Eastern plant maintenance activities could be offset by softer fertiliser and methanol prices, weak demand and crude oil prices.

“The stock is currently trading at a fair FY16F EV/EBITDA of 9.9 times, which is 68% above PTT Global Chemicals’ 5.9 times,” it said.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Wall St set to rise ahead of speeches from Fed officials
Sarawak Cable finds new hope as alternative party is identified
Main Market-bound Feytech IPO public portion oversubscribed
Bursa lifts Awantec's affected issuer status
SC charges Pixelvest and former Infinity Trustee director with unlicensed capital market offences
Ringgit ends firmer against US dollar
InNature buys 'Burger & Lobster' franchise, eyes expansion into F&B Sector
Bank Negara fines Habib with RM96,250 for AMLA non-compliance
Pharmaniaga says 'stands firm' on financial recovery to exit PN17
Kobay gets UMA query from Bursa Malaysia

Others Also Read